Figure S4 from ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer
Year: 2025
Type: other
Abstract: Figure S4. A, Immunoblot for TP53 and Vinculin in wildtype and ANGEL2-null HCT116 and RKO cells mocked treated or treated with Pen-Control (20 uM) for 18hrs. (B) Immunoblot for TP53 and GAPDH in RBM24/38-null RKO cells treated with Pen-Control, or Pen-Pep7 (20 μM) alone or in combination with doxorubicin (6.25 ng/mL) for 18hrs.
Authors: Christopher August Lucchesi, Saisamkalpa Mantrala, Darren Tran, Neelu Batra, Avani Durve, Conner Suen, Jin Zhang, Paramita Ghosh, Xinbin Chen
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4411967294